Blog
Is It Time to Ring the Register on Carvana's 1,000% Run?
Prices for both new and used vehicles have rocketed to all-time highs over the last 12 months, thanks to supply chain disruptions caused by the pandemic. The purchasing experience has been a
3 Reasons Shareholders of Moderna and BioNTech May Be In for a Shock
Shares of Moderna (NASDAQ: MRNA) and BioNTech (NASDAQ: BNTX) are up about 80% and 100% since the beginning of April, respectively. Much of that climb has been on the assumption that people receiving
Forget Apple: Here Are 3 Better Dividend Stocks
Apple is a great investment to buy and hold for years. But if you want to maximize your dividend income, you'll probably want to look elsewhere: Its 0.7% yield is not even close to the S&P 500
This Therapeutics Company Is Eyeing Zero Competition for the Next 5 Years
In February 2020, Horizon Therapeutics (NASDAQ: HZNP) launched what would become a successful drug in its arsenal of rare disease treatments: Tepezza, a treatment for thyroid eye disease. Little did
These 5 Bank Stocks Just Increased Their Dividends
We recently learned that all 23 banks that were subject to the 2021 stress tests passed with flying colors. And for the first time in the post-financial crisis era, banks have control over how much
Etsy's Land Grab Strategy Continues
Shares of Etsy (NASDAQ: ETSY) popped Monday, rising 7.4% after the artisan-based online marketplace announced yet another acquisition.
Etsy will take over Elo7, which it calls the Etsy of Brazil
Will All End Well for This Popular Reddit Biotech?
On June 28, shares of Cel-Sci (NYSEMKT: CVM) plunged nearly 70% peak-to-trough before recovering. The reason behind the wild price action couldn't be more obvious -- the company's pivotal phase 3
Is Novavax the Leader in Developing a Combo COVID/Flu Vaccine?
Novavax (NASDAQ: NVAX) hasn't won Emergency Use Authorization (EUA) for its COVID-19 vaccine yet. However, the company might do so relatively soon. It's also exploring the potential for a
Social Security Benefits Likely to Increase Next Year, Even if Biden Doesn't Act
Before taking office, President Joe Biden outlined several changes he wanted to make to Social Security -- many of which would increase retirement benefits. These changes included a higher minimum
3 Buffett Stocks You'll Never Have to Sell
Few, if any, investors have been more consistently successful over the long run than Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) CEO Warren Buffett. Folks might find his buy-and-hold tactics a bit
Big Banks Launch a Flurry of Dividend Increases: Here Are the Winners and Losers
Everyone knew the dividend increases were coming, and the big banks did not disappoint.
After roughly a year of limitations on capital distributions, the Federal Reserve announced last week that all
How Biogen Made an Enemy of 1 of the Biggest Supporters of Its Alzheimer's Disease Drug
Many in the scientific community weren't thrilled that the U.S. Food and Drug Administration (FDA) approved Biogen's (NASDAQ: BIIB) Aduhelm in treating Alzheimer's disease. They didn't think the
NVIDIA's Stock Split Is Almost Here: Here's What You Should Know
In late May, graphics chip-maker NVIDIA (NASDAQ: NVDA) surprised shareholders with an announcement that it would execute a four-for-one stock split. The stock split is finally almost here. Shares
This Insurance Broker Has Outperformed the S&P 500 Over the Past Decade: Should You Buy It?
When it comes to underappreciated winners, Marsh & McLennan (NYSE: MMC) is one stock that has outperformed the broader market for over a decade. The insurance broker has a solid history of steady
Forget AMC: Here Are 2 Better Post-Pandemic Stocks
AMC Entertainment Holdings (NYSE: AMC) closed its theaters during the pandemic and lost billions. But that didn't stop it from becoming one of the best-performing stocks year to date. A group of
Is Pfizer's Partner BioNTech About to Make a Big Blunder?
BioNTech (NASDAQ: BNTX) just might be the most underappreciated biotech on the planet. The German company initially developed the COVID-19 vaccine that caught Pfizer's (NYSE: PFE) attention. Many
These 3 Winners Look Ready for a Stock Split
Stock splits play a strange role in investing. On their face, they have no effect whatsoever on a company's value -- they simply change the number of outstanding shares a company has. Yet most
11 Words From Moderna's President That Could Mean Billions of Dollars in Additional Sales
When Dr. Stephen Hoge speaks, people listen. Hoge is president of Moderna (NASDAQ: MRNA), a drugmaker that's been one of the biggest winners in the COVID-19 vaccine market. He heads up the company's
5 Dividend Stocks to Buy Hand Over Fist for the Second Half of 2021
There are a number of ways for investors to build wealth on Wall Street. But if there's one near-constant for the world's most successful money managers, it's their love of dividend stocks.
5 Important Steps to Managing Your 401(k)
Saving independently for retirement is a great way to help ensure that you have enough money to cover your living expenses as a senior. While Social Security may provide you with a nice chunk of
Why Warren Buffett's $5 Billion Airline Debacle Wasn't Actually a Mistake
Warren Buffett might be one of the most successful investors in stock market history, but he doesn't hesitate to admit that he makes mistakes. In his long history at Berkshire Hathaway (NYSE: BRK.A)
Can DoorDash Take On Amazon?
It didn't take long for DoorDash (NYSE: DASH) to reach the top of the restaurant delivery heap.
Founded in 2013, well after rivals such as Uber and Grubhub, DoorDash now reigns supreme over the
Exxon Has Rallied, but I'm Still Glad I Switched to This Stock Instead
Shares of ExxonMobil (NYSE: XOM) have rallied 50% so far in 2021. That's an incredible run that is roughly twice as large as any of its major peers. At this point, my switch into TotalEnergies
Why The Original BARK Company Stock Surged 9.8% on Tuesday
Shares of The Original BARK Company (NYSE: BARK), a dog-centric omni-channel retailer, popped 9.8% on Tuesday, likely at least in part driven by a Wall Street analyst initiating coverage with a
Magellan Is Making Big Changes. Should Dividend Investors Worry?
One of the biggest reasons for buying units of Magellan Midstream Partners (NYSE: MMP) was its distribution, which has been increased annually since its 2001 IPO. But something major changed in 2020


